Literature DB >> 6323069

The syndromic status of sclerosteosis and van Buchem disease.

P Beighton, A Barnard, H Hamersma, A van der Wouden.   

Abstract

We have examined 50 persons with sclerosteosis in the Afrikaner community of South Africa and 15 individuals with van Buchem disease in Holland. The clinical and radiographic manifestations of these conditions are very similar, the only notable differences being greater severity and syndactyly in the majority of the patients with sclerosteosis. The Afrikaners have Dutch antecedants and it seems likely that these autosomal recessive disorders result from homozygosity of the same faulty genes. The phenotypic variation may be due to the epistatic effect of modifying genes in the Afrikaner population.

Entities:  

Mesh:

Year:  1984        PMID: 6323069     DOI: 10.1111/j.1399-0004.1984.tb00481.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  32 in total

1.  Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET.

Authors:  Jérôme J Waterval; Thijs M A Van Dongen; Robert J Stokroos; Jaap G J Teule; Gerrit J Kemerink; Boudewijn Brans; Fred H M Nieman; Johannes J Manni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-16       Impact factor: 9.236

Review 2.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 3.  Sclerosing bone dysplasias--a target-site approach.

Authors:  A Greenspan
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

4.  Sclerosteosis.

Authors:  P Beighton
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

5.  Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21.

Authors:  W Van Hul; W Balemans; E Van Hul; F G Dikkers; H Obee; R J Stokroos; P Hildering; F Vanhoenacker; G Van Camp; P J Willems
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 6.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

Review 7.  The Utility of Biomarkers in Osteoporosis Management.

Authors:  Patrick Garnero
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 8.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

9.  Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation.

Authors:  Matthew Tamplen; Tristan Fowler; Jeffery Markey; P Daniel Knott; Larry J Suva; Tamara Alliston
Journal:  Head Neck       Date:  2018-03-09       Impact factor: 3.147

10.  Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model.

Authors:  Mandeep S Virk; Farhang Alaee; Hezhen Tang; Michael S Ominsky; Hua Zhu Ke; Jay R Lieberman
Journal:  J Bone Joint Surg Am       Date:  2013-04-17       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.